A Perspective on the New American College of Cardiology/American Heart Association Guidelines for Cardiovascular Risk Assessment Iftikhar J. Kullo, MD, Jorge F. Trejo-Gutierrez, MD, MHS, Francisco Lopez-Jimenez, MD, MSc, Randal J. Thomas, MD, MSc, Thomas G. Allison, PhD, MPH, Sharon L. Mulvagh, MD, Adelaide M. Arruda-Olson, MD, PhD, Sharonne N. Hayes, MD, Amy W. Pollak, MD, Stephen L. Kopecky, MD, R. Todd Hurst, MD Mayo Clinic Proceedings Volume 89, Issue 9, Pages 1244-1256 (September 2014) DOI: 10.1016/j.mayocp.2014.06.018 Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 1 Derivation and validation of the atherosclerotic cardiovascular disease (ASCVD) risk calculator using pooled cohorts. Participants who met the following criteria were included: 40 to 79 years of age, apparently healthy, and no history of nonfatal myocardial infarction (recognized or unrecognized), stroke, heart failure, percutaneous coronary intervention, coronary artery bypass surgery, or atrial fibrillation. ARIC = Atherosclerosis Risk in Communities study; CARDIA = Coronary Artery Risk Development in Young Adults; CHS = Cardiovascular Health Study; FHS = Framingham Heart Study; SBP = systolic blood pressure; T2D = type 2 diabetes. Mayo Clinic Proceedings 2014 89, 1244-1256DOI: (10.1016/j.mayocp.2014.06.018) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions
Figure 2 Case studies. Mayo Clinic Proceedings 2014 89, 1244-1256DOI: (10.1016/j.mayocp.2014.06.018) Copyright © 2014 Mayo Foundation for Medical Education and Research Terms and Conditions